83 related articles for article (PubMed ID: 8628369)
1. Intensity of hemodialysis and response to erythropoietin.
Malhotra D; Tzamaloukas AH
N Engl J Med; 1996 Jun; 334(25):1669-70; author reply 1670-1. PubMed ID: 8628369
[No Abstract] [Full Text] [Related]
2. Intensity of hemodialysis and response to erythropoietin.
Kotanko P
N Engl J Med; 1996 Jun; 334(25):1670; author reply 1670-1. PubMed ID: 8628371
[No Abstract] [Full Text] [Related]
3. Intensity of hemodialysis and response to erythropoietin.
Uréna P; Pétrover M
N Engl J Med; 1996 Jun; 334(25):1669; author reply 1670-1. PubMed ID: 8628368
[No Abstract] [Full Text] [Related]
4. Intensity of hemodialysis and response to erythropoietin.
Ballinger AB; Fairclough PD; Clark ML; Farthing MJ
N Engl J Med; 1996 Jun; 334(25):1670; author reply 1670-1. PubMed ID: 8628370
[No Abstract] [Full Text] [Related]
5. [A hematocrit greater than 36 lessens mortality and hospitalization in hemodialysis].
Fernández-Gallego J; Gutiérrez C
Nefrologia; 2003; 23(2):177-8. PubMed ID: 12778885
[No Abstract] [Full Text] [Related]
6. [Use of erythropoietin in patients with chronic renal insufficiency and in hemodialysis].
Cuero CJ; Pérez Guardia E; de Rivera C
Rev Med Panama; 1996; 21(1-2):55-9. PubMed ID: 8966240
[TBL] [Abstract][Full Text] [Related]
7. Quality of life and its determinants of hemodialysis patients in Taiwan measured with WHOQOL-BREF(TW).
Yang SC; Kuo PW; Wang JD; Lin MI; Su S
Am J Kidney Dis; 2005 Oct; 46(4):635-41. PubMed ID: 16183418
[TBL] [Abstract][Full Text] [Related]
8. Erythropoietin for end-stage renal disease.
Adamson JW; Eschbach JW
N Engl J Med; 1998 Aug; 339(9):625-7. PubMed ID: 9718384
[No Abstract] [Full Text] [Related]
9. [Low doses of recombinant erythropoietin in the treatment of renal anemia in patients on chronic hemodialysis and ambulatory peritoneal dialysis].
Lashutin SV; Nikolaev AIu; Ermolenko VM; Shutov EV; Bezruk VG; Ivashchenko MA
Ter Arkh; 1999; 71(6):61-3. PubMed ID: 10420460
[TBL] [Abstract][Full Text] [Related]
10. [The effect of calcitriol on renal anemia in patients under chronic hemodialysis].
Abou-Khalil N; Makó J
Orv Hetil; 1996 Jul; 137(27):1469-72. PubMed ID: 9173368
[TBL] [Abstract][Full Text] [Related]
11. Circulating levels of thrombopoietin and erythropoietin in hemodialysis patients.
Otsubo Y; Nitta K; Otsubo S; Kimata N; Miwa N; Watanabe Y; Uchida K; Kawashima A; Yumura W; Akiba T; Nihei H
Acta Haematol; 2003; 109(4):209-11. PubMed ID: 12853697
[No Abstract] [Full Text] [Related]
12. Secondary hyperparathyroidism as cause of resistance to treatment with erythropoietin: effect of parathyroidectomy.
Goicoechea M; Gomez-Campdera F; Polo JR; Tejedor A; Ruiz MA; Vazquez I; Verde E; Valderrabano F
Clin Nephrol; 1996 Jun; 45(6):420-1. PubMed ID: 8793241
[No Abstract] [Full Text] [Related]
13. 2004 Japanese Society for Dialysis Therapy guidelines for renal anemia in chronic hemodialysis patients.
Gejyo F; Saito A; Akizawa T; Akiba T; Sakai T; Suzuki M; Nishi S; Tsubakihara Y; Hirakata H; Bessho M;
Ther Apher Dial; 2004 Dec; 8(6):443-59. PubMed ID: 15663544
[TBL] [Abstract][Full Text] [Related]
14. [Is the index of response to erythropoietin (IRE) a good marker of adequate dialysis?].
Pérez-García R; Rodríguez-Benítez P; Villaverde MT; Valderrábano F
Nefrologia; 2001; 21(6):606-7. PubMed ID: 11881433
[No Abstract] [Full Text] [Related]
15. Effect of recombinant human erythropoietin on soluble interleukin 2 receptor (SIL-2R) levels in haemodialysis patients.
Altun B; Erdem Y; Haznedaroğlu I; Gürsoy M; Yasavul U; Turgan C; Cağlar S; Kirazli S
Nephrol Dial Transplant; 1995 Nov; 10(11):2164. PubMed ID: 8643199
[No Abstract] [Full Text] [Related]
16. Maintenance therapy with intravenous iron in hemodialysis patients receiving erythropoietin.
Kotaki M; Uday K; Henriquez M; Blum S; Dave M
Clin Nephrol; 1997 Jul; 48(1):63-4. PubMed ID: 9247787
[No Abstract] [Full Text] [Related]
17. Anemia of chronic kidney disease and end-stage renal disease: are there unique issues in disadvantaged populations?
Obrador GT
Ethn Dis; 2009; 19(1 Suppl 1):S1-52-5. PubMed ID: 19484876
[TBL] [Abstract][Full Text] [Related]
18. [Evolution of medical practice in the care of anemia amd the use of erythropoietin in chronic renal insufficiency hemodialysis in the past six years].
Canaud B; Richard A; Fagnani F; Moreau-Defarges T; Guillon P
Nephrologie; 2002; 23(3):123-30. PubMed ID: 12087809
[TBL] [Abstract][Full Text] [Related]
19. [Effect of deferoxamine on erythropoiesis in patients hemodialyzed for chronic renal insufficiency treated with erythropoietin].
Kalinowski M; Popławski A; Kaliszewski Z; Juzwiuk J
Pol Merkur Lekarski; 1996 Oct; 1(4):232-4. PubMed ID: 9156931
[TBL] [Abstract][Full Text] [Related]
20. Loss of captopril-bound Fe by end-stage renal failure patients during hemodialysis.
Averbukh Z; Berman S; Kishinevsky E; Feldman L; Cohn M; Rapoport M; Galperin E; Dishi V; Weissgarten J
J Nephrol; 2004; 17(1):101-6. PubMed ID: 15151265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
